Neurological Sciences

, Volume 35, Issue 8, pp 1189–1196

Genome-wide pathway analysis in attention-deficit/hyperactivity disorder

Original Article


This study aimed to (1) to identify candidate single-nucleotide polymorphisms (SNPs) and mechanisms of attention-deficit/hyperactivity disorder (ADHD) and (2) to generate SNP-to-gene-to-pathway hypotheses. An ADHD genome-wide association study (GWAS) dataset that included 428,074 SNPs in 924 trios (2,758 individuals) of European descent was used in this study. The Identify candidate Causal SNPs and Pathways (ICSNPathway) analysis was applied to the GWAS dataset. ICSNPathway analysis identified 11 candidate SNPs, 6 genes, and 6 pathways, which provided 6 hypothetical biological mechanisms. The strongest hypothetical biological mechanism was that rs2532502 alters the role of CD27 in the context of the pathways of positive regulation of nucleocytoplasmic transport [nominal p < 0.001; false discovery rate (FDR) = 0.028]. The second strongest mechanism was the rs1820204, rs1052571, rs1052576 → CASP9 → mitochondrial pathway (nominal p < 0.001; FDR = 0.032). The third mechanism was the rs1801516 → ATM → CD25 pathway (nominal p < 0.001; FDR = 0.034). By applying the ICSNPathway analysis to the ADHD GWAS data, 11 candidate SNPs, 6 genes that included CD27, CASP9, ATM, CD12orf65, OXER1, and ACRY, and 6 pathways were identified that may contribute to ADHD susceptibility.


Attention-deficit/hyperactivity disorder Genome-wide association study Pathway-based analysis 


  1. 1.
    Franke B, Faraone SV, Asherson P, Buitelaar J, Bau CH, Ramos-Quiroga JA, Mick E, Grevet EH, Johansson S, Haavik J, Lesch KP, Cormand B, Reif A, International Multicentre Persistent ADHD Collaboration (2012) The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry 17:960–987PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Manolio TA (2010) Genomewide association studies and assessment of the risk of disease. N Engl J Med 363:166–176PubMedCrossRefGoogle Scholar
  3. 3.
    Choi SJ, Rho YH, Ji JD, Song GG, Lee YH (2006) Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 45:166–170CrossRefGoogle Scholar
  4. 4.
    Lee YH, Nath SK (2005) Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet 118:434–443PubMedCrossRefGoogle Scholar
  5. 5.
    Johnson AD, O’Donnell CJ (2009) An open access database of genome-wide association results. BMC Med Genet 10:6PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Boomsma DI, Willemsen G, Sullivan PF, Heutink P, Meijer P, Sondervan D, Kluft C, Smit G, Nolen WA, Zitman FG, Smit JH, Hoogendijk WJ, van Dyck R, de Geus EJ, Penninx BW (2008) Genome-wide association of major depression: description of samples for the GAIN Major Depressive Disorder Study: NTR and NESDA biobank projects. Eur J Hum Genet 16:335–342PubMedCrossRefGoogle Scholar
  7. 7.
    Wang K, Li M, Hakonarson H (2010) Analysing biological pathways in genome-wide association studies. Nat Rev Genet 11:843–854PubMedCrossRefGoogle Scholar
  8. 8.
    Lee YH, Song GG (2012) Pathway analysis of genome-wide association studies on uric acid concentrations. Hum Immunol 73:805–810PubMedCrossRefGoogle Scholar
  9. 9.
    Zhang K, Chang S, Cui S, Guo L, Zhang L, Wang J (2011) ICSNPathway: identify candidate causal SNPs and pathways from genome-wide association study by one analytical framework. Nucleic Acids Res 39:W437–W443PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Kuntsi J, Neale BM, Chen W, Faraone SV, Asherson P (2006) The IMAGE project: methodological issues for the molecular genetic analysis of ADHD. Behav Brain Funct 2:27PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Coghill D, Banaschewski T (2009) The genetics of attention-deficit/hyperactivity disorder. Expert Rev Neurother 9:1547–1565PubMedCrossRefGoogle Scholar
  12. 12.
    Croft M (2009) The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 9:271–285PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Wurstle ML, Laussmann MA, Rehm M (2012) The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome. Exp Cell Res 318:1213–1220PubMedCrossRefGoogle Scholar
  14. 14.
    Carlessi L, Fusar Poli E, De Filippis L, Delia D (2013) ATM-deficient human neural stem cells as an in vitro model system to study neurodegeneration. DNA Repair (Amst) 12(8):605–611CrossRefGoogle Scholar
  15. 15.
    Duarte I, Nabuurs SB, Magno R, Huynen M (2012) Evolution and diversification of the organellar release factor family. Mol Biol Evol 29:3497–3512PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46–56PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Pardo CA, Vargas DL, Zimmerman AW (2005) Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 17:485–495PubMedCrossRefGoogle Scholar
  18. 18.
    Balestrieri E, Pitzianti M, Matteucci C, D’Agati E, Sorrentino R, Baratta A, Caterina R, Zenobi R, Curatolo P, Garaci E, Sinibaldi-Vallebona P, Pasini A (2013) Human endogenous retroviruses and ADHD. World J Biol Psychiatry. doi:10.3109/15622975.2013.862345
  19. 19.
    Mann JR, McDermott S (2011) Are maternal genitourinary infection and pre-eclampsia associated with ADHD in school-aged children? J Atten Disord 15:667–673PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2014

Authors and Affiliations

  1. 1.Division of Rheumatology, Department of Internal Medicine, Korea University Anam HospitalKorea University College of MedicineSeoulKorea

Personalised recommendations